Assistant Professor of Pharmaceutical Sciences
Dr. Rob Hilgers obtained his Ph.D degree in Pharmacology at the University of Maastricht, the Netherlands in 2004. He has substantial postdoctoral research experience in cardiovascular-related diseases conducted at prestigious universities in Europe and the United States. His particular interests involves studying the molecular mechanisms of endothelial dysfunction in resistance arteries in experimental animal models of hypertension, aging and obesity-induced diabetes.His main expertise is the application of myograph systems to assess ex vivo vascular reactivity and structure in correlation with pharmacological interventions. He is particularly interested in the role of endothelial calcium-activated potassium channels in relation to cellular redox status.
×
About Rob Hilgers
Dr. Rob Hilgers obtained his Ph.D degree in Pharmacology at the University of Maastricht, the Netherlands in 2004. He has substantial postdoctoral research experience in cardiovascular-related diseases conducted at prestigious universities in Europe and the United States. His particular interests involves studying the molecular mechanisms of endothelial dysfunction in resistance arteries in experimental animal models of hypertension, aging and obesity-induced diabetes.His main expertise is the application of myograph systems to assess ex vivo vascular reactivity and structure in correlation with pharmacological interventions. He is particularly interested in the role of endothelial calcium-activated potassium channels in relation to cellular redox status.
| Present | Assistant Professor of Pharmaceutical Sciences, Campbell University ‐ College of Pharmacy and Health Sciences | |
|
|
||
Disciplines
Grants
| 2018 | Implementation of PK/PD software training for PharmD and Master of Sciences students |
| Campbell University | |
| Faculty Development Grant | |
| $2,500 | |
| 2016 | Vascular redox control of hyperlipidemia-induced coronary artery dysfunction and atherosclerosis |
| South Plains Foundation | |
| Role: Principal Investigator | |
| $15,000 | |
| 2009 | Vasodilator effects of estetrol in rat arteries |
| Pantarhei Bioscience | |
| Role: Principal Investigator | |
| $50,000 |
Professional Service and Affiliations
| Member, American Association for the Advancement of Science | Member, American Association of Colleges of Pharmacy | Member, American Heart Association | Member, American Physiological Society |
Honors and Awards
- Graduate Student Travel Award of the American Society for Pharmacology and Experimental Therapeutics (ASPET) at the Experimental Biology ’01, Orlando, FL, March 31-April 4, 2001
- Pre-doctoral Marie Curie European Fellowship, March 2002-September 2002
- Young Investigator Award European Council for Blood Pressure and Cardiovascular Research (ECCR), Seeheim, Germany, October 10-12, 2003
- Graduate Student Travel Award of the American Society for Pharmacology and Experimental Therapeutics (ASPET) at the Experimental Biology ’05, San Diego, CA, April 2-6, 2005
- Graduate Student Travel Award of the American Society for Pharmacology and Experimental Therapeutics (ASPET) at the Experimental Biology ’06, San Francisco, CA, April 1-5, 2006
Courses
- PHSC 592, Advanced Pharmacology (Co-Director)
- PPCII, Pharmaceutics, Pharmacokinetics & Calculations (Course Director)
- PHSC 574, Biopharmaceutics (Course Director)
- PHSC 510, Advanced Pharmacokinetics (Course Director)